Search by Journal
- HOME
- > Search by Journal
- > Neurological Therapeutics
Neurological Therapeutics
Volume 29, Issue 5 / 2012
English Article Japanese Article
- Please note that metadata of J-type articlesare generated by machine-translation and the original texts are written in Japanese.
Treatment of the neurologic disease judging from neurophysiology 辻貞俊 Neurological Therapeutics 29(5): 553-553, 2012. |
1 Comparison of the effectiveness and complications of medical, surgical and alternative therapies for patients with intractable epilepsy Hans O Luders Neurological Therapeutics 29(5): 554-554, 2012. |
2 ALS Update : How to improve patient care in ALS Hiroshi MITSUMOTO Neurological Therapeutics 29(5): 555-555, 2012. |
1 days gone by, future 平山惠造 Neurological Therapeutics 29(5): 556-556, 2012. |
From this of 2 Japan neurotherapeutics societies Yasuto Itoyama Neurological Therapeutics 29(5): 557-557, 2012. |
Strategies for treatment of 1 vascular dementia Tomimoto Hidekazu Neurological Therapeutics 29(5): 558-558, 2012. |
The present conditions of the treatment with 2 botulinum toxin and new development Nakamura male product Neurological Therapeutics 29(5): 559-559, 2012. |
A new disease modifier of 3 multiple sclerosis towards Disease activity free status: The Matsui truth Neurological Therapeutics 29(5): 560-560, 2012. |
Molecular treatment of 4 muscular dystrophy Yoshihide Sunada Neurological Therapeutics 29(5): 561-561, 2012. |
From knowledge to help 5 hereditary neuropathic summary - practice to molecular clinical condition - Hiroshi Takashima Neurological Therapeutics 29(5): 562-562, 2012. |
Basics of 1 electroencephalogram reading Tobimatsu Shozo Neurological Therapeutics 29(5): 563-563, 2012. |
Foundations of 2 electromyograms 有村公良 Neurological Therapeutics 29(5): 564-564, 2012. |
Neurology to see on 3 videos Eiichiro Mukai Neurological Therapeutics 29(5): 565-565, 2012. |
4 muscular dystrophy Nishino Ichizo Neurological Therapeutics 29(5): 566-566, 2012. |
MRI diagnosis of 5 ataxia Koichiro Okamoto Neurological Therapeutics 29(5): 567-567, 2012. |
baclofen intraspinal injection treatment for 1 spasticity Yutaka Naito Neurological Therapeutics 29(5): 568-568, 2012. |
A diagnosis and treatment of 2 peripheral vertigo Hideaki Suzuki Neurological Therapeutics 29(5): 569-569, 2012. |
3 eyelids contractions, apraxia of lid opening, art of the botulinum toxin therapy in the hemifacial spasm Takahiro Mesaki Neurological Therapeutics 29(5): 570-570, 2012. |
Pain of 4 Parkinson disease, spinal cord stimulation for the abnormal posture Takeshi Saito Neurological Therapeutics 29(5): 571-571, 2012. |
Vagal impulse therapy in 5 epilepsy treatment Takashi Yamamoto way Neurological Therapeutics 29(5): 572-572, 2012. |
Development and the spread of low fixed-quantity continuation sputum aspirator It is figure Yoichi law Neurological Therapeutics 29(5): 573-573, 2012. |
A change of the medical treatment environment and choice of the respirator Takenori Uozumi 1, Yuko Nakagawa 1, Upper three fence Kazue 2, 辻貞俊 3 Neurological Therapeutics 29(5): 574-574, 2012. |
Team approach in medical care in the nerve intractable disease home mechanical ventilation Mieko Ogino Neurological Therapeutics 29(5): 575-575, 2012. |
The present conditions and problems of the communication support of the nerve intractable disease (ALS in particular) patients who undergo at home medical treatment using a respirator Narita Yugo Neurological Therapeutics 29(5): 576-576, 2012. |
Next-generation Alzheimer medicine development: The molecular condition of a patient and treatment of Aβ in cells with apomorphine 大八木保政 Neurological Therapeutics 29(5): 577-577, 2012. |
For basic treatment of Alzheimer disease Hideo Hara Neurological Therapeutics 29(5): 578-578, 2012. |
Understanding of the Aβ metabolism system for the initiative medical care development of Alzheimer disease 富田泰輔 Neurological Therapeutics 29(5): 579-579, 2012. |
Likelihood of dementia treatment by the tau agglomeration inhibition Akihiko Takashima Neurological Therapeutics 29(5): 580-580, 2012. |
Progress of epilepsy treatment Akio Ikeda Neurological Therapeutics 29(5): 581-581, 2012. |
Treatment with latest anticonvulsant Hiroshi Shigefuji Neurological Therapeutics 29(5): 582-582, 2012. |
Mainly on epidemiology elderly people epilepsy of epilepsy Akihiro Tanaka Neurological Therapeutics 29(5): 583-583, 2012. |
Total care of epilepsy Masahiro Mizobuchi Neurological Therapeutics 29(5): 584-584, 2012. |
For the making of ALS practice new guidelines Imaharu Nakano Neurological Therapeutics 29(5): 585-585, 2012. |
Guillain-Barre syndrome, Fisher syndrome practice guidelines 楠進 Neurological Therapeutics 29(5): 586-586, 2012. |
New nerve practice guidelines on CIDP/MMN Origin of Sofue Neurological Therapeutics 29(5): 587-587, 2012. |
Chronic headache practice guidelines Nobuo Araki Neurological Therapeutics 29(5): 588-588, 2012. |
New nerve practice guidelines - bacterial meningitis Satoshi Kamei Neurological Therapeutics 29(5): 589-589, 2012. |
Action of the Japan Medical Association trial promotion center for trial promotion Manabu Yamamoto Neurological Therapeutics 29(5): 590-590, 2012. |
The present conditions and problem of the medical supplies development of our country which we looked at from the examination authorities Yoshiaki Uyama Neurological Therapeutics 29(5): 591-591, 2012. |
New movement of the drug industry for the new drug development of the neurologic disease region Yoko Fujimoto Neurological Therapeutics 29(5): 592-592, 2012. |
Challenge to therapy development for amyotrophic lateral sclerosis Masashi Aoki Neurological Therapeutics 29(5): 593-593, 2012. |
Basics of 1 epilepsy treatment Naoki Akamatsu Neurological Therapeutics 29(5): 594-594, 2012. |
Basic policy of 2 cerebral infarction acute care Shunsuke Otsuki Neurological Therapeutics 29(5): 595-595, 2012. |
Basics of 3 myasthenia gravis treatment Masakatsu Motomura Neurological Therapeutics 29(5): 596-596, 2012. |
It is a diagnosis and the treatment of the intractable headache 4 cluster headaches, trigeminal nerve autonomy nervous headache, chronic day after day sex headache Takeshima Taga husband Neurological Therapeutics 29(5): 597-597, 2012. |
Understanding and help of 5 dementia Takahiro Sugiyama Neurological Therapeutics 29(5): 598-598, 2012. |
6 dysphagia Kiyoharu Inoue Neurological Therapeutics 29(5): 599-599, 2012. |
Correspondence to a non-exercise symptom of 7 Parkinson disease Yasuyuki Okuma Neurological Therapeutics 29(5): 600-600, 2012. |
8 carpal tunnel syndrome Garden Masahiro Neurological Therapeutics 29(5): 601-601, 2012. |
Strategies for treatment in 9 anti-NMDA receptor encephalitis 飯塚高浩 Neurological Therapeutics 29(5): 602-602, 2012. |
Treatment of 10 essential tremors Kenji Nakajima Neurological Therapeutics 29(5): 603-603, 2012. |
Basics of 11 multiple sclerosis treatment Kazuo Fujiwara Neurological Therapeutics 29(5): 604-604, 2012. |
12 hemifacial spasm 梶龍兒 Neurological Therapeutics 29(5): 605-605, 2012. |
Practice of 13 chronic pain 岡田和将 Neurological Therapeutics 29(5): 606-606, 2012. |
Clinical significance of 1 new anticonvulsant Tadashi Kaneko Neurological Therapeutics 29(5): 607-607, 2012. |
2 old anticonvulsant has enough effect of treatment now Hirose source Jiro Neurological Therapeutics 29(5): 608-608, 2012. |
Effect on cerebration in the "depression" expression patients by 1 Interferon Akihiko Morita Neurological Therapeutics 29(5): 609-609, 2012. |
Including the treatment of preventive therapy - substance abuse headache of the migraine headache with 2 valproic acid Kazuhiro Muramatsu Neurological Therapeutics 29(5): 610-610, 2012. |
Application to neurologic disease of 3 Ritsu xanthan gum Takashi Inuzuka Neurological Therapeutics 29(5): 611-611, 2012. |
One case of tuberculous meningitis that suffered from 1B-01 treatment, and responded to intramuscular injection of streptomycin Kanako Yasui, Seiichi Ono Neurological Therapeutics 29(5): 615-615, 2012. |
Follow 1B-02 subacute course; cerebral infarction, one case of enterococcal meningitis who had cerebral hemorrhage Maho Hirayama, Naoyuki Kitagawa, Nobuko Sakai, Yasuo Aota, Michio Sakurai Neurological Therapeutics 29(5): 615-615, 2012. |
The case which showed an intracranial diffuse lesion with 1B-03 sepsis Manabu Matsuya, 有吉直充 Neurological Therapeutics 29(5): 615-615, 2012. |
One case of the chronic meningitis that racked its brains about 1B-04 diagnosis Akira Shindo University 1, Yuichiro Ii 1, Motonobu Mori 2, 柴田益成 3, Tomimoto Hidekazu 1 Neurological Therapeutics 29(5): 615-615, 2012. |
The 29 years old man case that repeated bacterial meningitis 14 years after a previous basal skull fracture due to the 1B-05 traffic injury Yoshiyuki Sasaki 1, Fuyuki Tateno 1, Yohei Tsuyusaki 1, Masahiko Kishi 1, Takatsugu Sakakibara 1, Shunpei Ando 2, Takao Kuroki 2, Ken Nagao tree 2 Neurological Therapeutics 29(5): 616-616, 2012. |
One case of adult type B influenza-associated encephalopathy that responded to 1B-06 combined modality therapy Tomoko Takeda, Asako Ueno, Tomoko Muramatsu, Masamichi Igawa, Osamu Yamamura, Tadanori Hamano, Makoto Yoneta Neurological Therapeutics 29(5): 616-616, 2012. |
The 52 years old woman case that caused the multiple cranial nerve palsies due to the 1B-07 herpes zoster virus Yoshiyuki Sasaki, Fuyuki Tateno, Yohei Tsuyusaki, Masahiko Kishi, Takatsugu Sakakibara Neurological Therapeutics 29(5): 616-616, 2012. |
One case of herpes zoster virus encephalomyelitis that 1B-08 central nerve symptom was preceded by for eruption Shunsuke Usami 1, Your Satoru Tanaka 2, Masato Osaki 3, Hiroshi Moriwaki 4, Kotaro Miyashita 2, Long bunch party 2 Neurological Therapeutics 29(5): 616-616, 2012. |
One case of meningoencephalitis by cryptococcus var. gattii which was resistant to a lot of 1B-09 treatment Kawamoto is unknown, 関谷博顕, Good luck Nobuo Hara Neurological Therapeutics 29(5): 617-617, 2012. |
1 severe case of brain cryptococcosis that led to complete cure by long-term maintenance therapy of 1B-10 Voriconazole Yoshiwara chapter king 1, Kazuhiro Endo 1, 2, Shunsuke Kobayashi 1, Nozomi Matsuda 1, Noboru Nakahara will tree 1, 3, Sanae Takahashi 1, Yoshikazu Ugawa 1 Neurological Therapeutics 29(5): 617-617, 2012. |
Image change of the brain MRI after the albendazole treatment of the 1B-11 brain cysticercosis 保月隆良 1, Imai wealth 2, Emiko Tsuda 2, Rika Yamauchi 2, Susumu Kikuchi 1, 下濱俊 2 Neurological Therapeutics 29(5): 617-617, 2012. |
58 years old woman case of progressive multifocal leukoencephalopathy with the SLE that did not respond to 1B-12 Mefloquine Deepest-placed shrine Taro, Kanbe Daisuke, New appearance Akiyo, Suenaga Toshihiko Neurological Therapeutics 29(5): 617-617, 2012. |
Effect of the angiotensin II receptor blocker in the 1B-13 experimental autoimmune neuritis Toshiki Fujioka, Masashi Inoue, Hisao Kitazono, Shingo Konno Neurological Therapeutics 29(5): 618-618, 2012. |
One case that carotid artery stenting was effective for recurrent cerebral infarction from 1C-01 ulcerative lesion 岡村穏 1, 竹川英宏 1, Shinya Yamamoto 1, Yohei Asakawa 1, Fumika Numao 2, Keisuke Suzuki 2, Koichi Hirata 2 Neurological Therapeutics 29(5): 619-619, 2012. |
One case of the vasculitis that assumed the bilateral internal carotid arteries that 1C-02 steroid and antithrombotic therapy were effective the main locus and juvenile cerebral infarction thought about Kazuki Fukuma, Satoko Nakashita, Kenji Wada, Kowa Hisanori, Kenji Nakajima Neurological Therapeutics 29(5): 619-619, 2012. |
One patient who performed urgent STA-MCA bypass operation for 1C-03 right internal carotid artery obstruction, and was able to obtain a good outcome Tomoko Yoshida 1, Takuya Oguri 1, Mino Ueki 1, Noriyuki Matsukawa 1, Kentaro Yamada 2, Hisafumi Sagisaka 3, Yukio Kojika 3 Neurological Therapeutics 29(5): 619-619, 2012. |
1 case that was thought to develop thrombotic microan-giopathy(TMA) by 1C-04 Interferonβ-1b preparation 山崎真平, 中神由香子, 岡田洋一郎, 長谷佳樹, 猪原匡史, 福山秀直, 植村健吾, 高橋良輔 Neurological Therapeutics 29(5): 619-619, 2012. |
One case of the diabetic choreiform involuntary movement improved by 1C-05 cerebral infarction treatment Yutaka Suzuki, Yo Sugano, Katsuhiko Ogawa, Hiroshi Shiota, Minoru Oishi, Satoshi Kamei Neurological Therapeutics 29(5): 620-620, 2012. |
One case of brainstem type posterior reversible encephalopathy syndrome which was arrested at the 1C-06 cerebral infarction onset, and was improved by slow depression Daisuke Honda, Kawagashira Yuichi, Yuzuru Senda, Naoki Atsuta, 渡辺宏久, Origin of Sofue Neurological Therapeutics 29(5): 620-620, 2012. |
Precritical treatment by 1C-07 non-valvular atrial fibrillation turn of eventss of the cardioembolic Takehiko Nagao 1, Kazumasa Arii 2, Hideki Takubo 2, Tairo Katayama 3, Shinichiro Uchiyama 1 Neurological Therapeutics 29(5): 620-620, 2012. |
One case of malignant middle cerebral artery infarction which was able to perform outside decompression procedure 10.5 hours after 1C-08 Alteplase administration Yuko Nakamura, Tomoaki Kameda, Haruo Shimazaki, Kunihiko Ikeguchi, Imaharu Nakano Neurological Therapeutics 29(5): 620-620, 2012. |
Examination of the cardioembolic given 1C-09 rt-PA therapy Tetsuya Abe, 廣重美和, Fortune Toshihiro Sako Neurological Therapeutics 29(5): 621-621, 2012. |
One case of the rt-PA intravenous-injection treatment non-adaptation that obtained good course during correspondence with 1C-10 t-PA mode Masaya Kumamoto 1, Kuniyasu Wada 1, Yasuyuki Hara 1, Shuji Terasaki 1, Yuki Ando male 2 Neurological Therapeutics 29(5): 621-621, 2012. |
Significance of the MRI in the adaptation decision of the transvenous thrombolytic therapy in patients with 1C-11 acute ischemic stroke Ei Tanaka Jiro 1, Tomoyuki Ohara 1, Kazunori Toyota 1, Miyashita under-secretary 1, Long bunch party 2, Kazuo Minematsu 1 Neurological Therapeutics 29(5): 621-621, 2012. |
1C-12 That there is no acute cerebral deep white matter lesions I predict a good outcome after intravenous tPA therapy 河野浩之1, 平野照之2, 稲富雄一郎1, 寺崎修司3, 米原敏郎1 Neurological Therapeutics 29(5): 621-621, 2012. |
Histories of treatment of the old partial epilepsy case that consulted memory clinic in chief complaint in 1D-01 forgetfulness Kazuhiro Muramatsu 1, Yasuhiro Nagashima 1, Naoko Ogura 1, Michiyuki Maruyama 1, Country book Masaya 2 Neurological Therapeutics 29(5): 622-622, 2012. |
One case of the epileptic higher nervous function that 1D-02 amnesia improved in lamotrigine Sugimoto Azusa, Akinori Nimura, Satoshi Yano, Mitsuru Kawamura Neurological Therapeutics 29(5): 622-622, 2012. |
It is use experience in this hospital a little combination of the 1D-03 new anticonvulsant Takahiro Saegusa, Mai Hagiwara, Manabe Kenro, Yoshifumi Nakatani, Matsui University Neurological Therapeutics 29(5): 622-622, 2012. |
Examination of 20 effective - one's own experiments of lamotrigine for patients with 1D-04 adults epilepsy Naoki Hattori, Shohei Ikeda, Wataru Takita, Tetsuro Ishihara Neurological Therapeutics 29(5): 622-622, 2012. |
One case of for a short time persistent unilateral neuralgiform headache attack (SUNCT) with hyperemia of conjunctiva and the dacryorrhea treated effectively with 1D-05 Pregabalin Shoji Kikui, Susumu Yamashita, Takeshima Taga husband Neurological Therapeutics 29(5): 623-623, 2012. |
Migraine headache preventive therapy in the headache outpatient department after the 1D-06 Valproate acid insurance adaptation Hisashi Iwanami authority 1, Person from dragon former sect 1, Toshihiko Shimizu 2, Koichi Hirata 1 Neurological Therapeutics 29(5): 623-623, 2012. |
Is the muscle relaxant effective for 1D-07 cluster headaches? Kenji Takagi, Kaoru Yamazaki, Mio Arai, Itsu Nojima, Ei Kobayashi kernel, Plum Tokyoku Neurological Therapeutics 29(5): 623-623, 2012. |
Are the patients and the caregiver satisfied with botulinum toxin treatment for the 1D-08 spasticity? Hisashi Ito 1, Great quantity lawn seedling 1, Hiroki Watanabe 2, Toru Kamei original 1 Neurological Therapeutics 29(5): 623-623, 2012. |
Migraine protective efficacy of 1D-09 Botulinum toxin type A Miki Osawa male, Megumi Takeuchi, Shinichiro Uchiyama Neurological Therapeutics 29(5): 624-624, 2012. |
One case that a percutaneous atrial septum choke by 1D-10 Amplatzer septal occluder developed migraine with aura postoperatively Yuji Kato, Onori Furuya, Norio Tanahashi Neurological Therapeutics 29(5): 624-624, 2012. |
Comparison - of patients with effect - migraine headache and the healthy adults whom acupuncture stimulation using the 1D-11 Arterial spin labeling MRI gives to cerebral blood flow Tomokazu Kikuchi 1, Satoshi Yamaguchi 1, Hiroshi Omata 1, Shinri Suzuki 1, Nobuo Araki 2 Neurological Therapeutics 29(5): 624-624, 2012. |
About ramelteon treatment for 1D-12 REM sleep behavior disorder Tetsushi Nomura, Shinya Kawase, 渡邉保裕, Kenji Nakajima Neurological Therapeutics 29(5): 624-624, 2012. |
One case of myasthenia gravis that, however, needed respiratory care during 1E-01 immunoglobulin therapy enforcement, and was improved by an immune adsorption therapy immediately 王子聡, Wataru Hara, Osamu Suzuki person, 深浦彦彰, Kyoichi Nomura Neurological Therapeutics 29(5): 625-625, 2012. |
One case of senile-onset myasthenia gravis that responded to addition of 1E-02 intravenous immune globulin therapy (IVIg) Large quantity lawn seedling, Hisashi Ito, Toru Kamei plus Neurological Therapeutics 29(5): 625-625, 2012. |
1 case of antiSRP antibody positive myopathy treated effectively with the a large quantity of intravenous injection immunoglobulin therapy that it was like 1E-03 regularly Kanako Kato 1, Masanobu Mizuno 1, Yasuo Terayama 1, Nishino Ichizo 2 Neurological Therapeutics 29(5): 625-625, 2012. |
Use experience of the immunoglobulin therapy by the strategies for treatment strong in 1E-04 early stage Yuriko Nagane, The spear swamp New Komeito Neurological Therapeutics 29(5): 625-625, 2012. |
About efficacy of the immunoglobulin large quantities intravenous-injection treatment for refractory myasthenia gravis with the 1E-05 long-term contraction of a disease period South Naoya 1, Jun Tashiro 1, Xinye Masaaki 2, Naoto Fujiki 1, Shizuka Doi tree 1, Seishi Kikuchi 1 Neurological Therapeutics 29(5): 626-626, 2012. |
Comparison between acute care <blood purification therapy for 1E-06 antiAChR antibody-positive myasthenia gravis and immunoglobulin high dose therapy> Hidekazu Suzuki, Mari Kitada, Rino Inada, Shigeru Kawai, Mao Okazaki, Juri Ichihashi, Yoshinobu Mitsui, 楠進 Neurological Therapeutics 29(5): 626-626, 2012. |
Effect of tacrolimus on 1E-07 ocular muscles type myasthenia gravis Icehouse Keiichi, Naoki Kawaguchi, Satoshi Kuwahara Neurological Therapeutics 29(5): 626-626, 2012. |
Effect of treatment by the tacrolimus early single administration as the initial treatment for 1E-08 myasthenia gravis Kengo Fujita, Sum hand Reika, Ei Kaneko, Hirofumi Kusaka Neurological Therapeutics 29(5): 626-626, 2012. |
41 years old man case of diabetes merger myasthenia gravis that impaired glucose tolerance improved by 1E-09 Tacrolimus cancellation rapidly Taro Sakauchi 1, Ryo Otomo 1, Hitoshi Aizawa 2, Yasushi Terao straight 1, Jun Shimizu 1, Goto order 1, Shoji Tsuji 1 Neurological Therapeutics 29(5): 627-627, 2012. |
One case of steroid-resistant MuSK antibody-positive MG where 1E-10 Mao-to (ephedrin) was effective Mukaino Akihiro 1, Masakatsu Motomura 1, Measure field Tomoko 1, Hideki Nakajima 1, Tei Miyazaki Ichiro 1, Nakata るか 1, Rie Ota 1, 吉村俊祐 1, Toshiaki Yoshimura 1, Shingo Ishitobi 2, Jun Kawakami 1 Neurological Therapeutics 29(5): 627-627, 2012. |
Histories of treatment of the super old systemic type myasthenia gravis (MG) case having complications of a lot of 1E-11 Kanbe Daisuke 1, Deepest-placed shrine Taro 1, 樽野陽亮 2, New appearance Akiyo 1, Suenaga Toshihiko 1 Neurological Therapeutics 29(5): 627-627, 2012. |
Brothers case of congenital myasthenic syndrome that responded to 1E-12 Prednisolone 福留隆泰 1, Ryuta Tanaka 2, Masakatsu Motomura 3, 東慶輝 4, Kinji Ono 4 Neurological Therapeutics 29(5): 627-627, 2012. |
Efficacy of the brain depth stimulation treatment for camptocormia in 1F-01 Parkinson disease Toshinari Nakane 1, 2, 福留隆泰 1, 2, Ei Urasaki Ichiro 3, Yuichi Shiraishi 2, Kazuka Sakai 2, Matsuya silk tree 2, Yuichiro Gondo 2, Akiko Nagaishi 2, Hidenori Matsuo 2 Neurological Therapeutics 29(5): 628-628, 2012. |
3 cases that deep brain stimulation therapy (DBS) was useful for the Parkinson disease (PD) patients who presented with a 1F-02 impulse control disorder Satoshi Sato, Takayuki Yuasa, Yoko Nakao, Hideyo Sato, Itsuro Tomita, Makiko Seto, Crossroads field Mitsuhiro Neurological Therapeutics 29(5): 628-628, 2012. |
One case of Parkinson disease that a pacing board was effective for severe palilalia that produced 1F-03 brain depth stimulation postoperatively Junichiro Suzuki 1, Yasuhiro Tanaka 1, 渡辺宏久 1, Naoki Atsuta 1, 伊藤瑞規 1, Yasukazu Kajita 2, Sofue former 1 Neurological Therapeutics 29(5): 628-628, 2012. |
Improvement of the exercise symptom with the spinal cord stimulation as 1F-04 Parkinson disease pain treatment Tadashi Ichikawa Neurological Therapeutics 29(5): 628-628, 2012. |
Long-term follow-up of dysphagia to be found in 1F-05 Parkinson's syndrome Hirokazu Furuya 1, Akira Watanabe Expo 1, Arahata wound 1, Joji Umemoto 2 Neurological Therapeutics 29(5): 629-629, 2012. |
An effect of the short-term rehabilitation on 1F-06 Parkinson disease and the evaluation Shoji Iijima 1, Yuko Kurono 1, Original one 1, Country book Masaya 2 Neurological Therapeutics 29(5): 629-629, 2012. |
Trial of the steroid therapy for the kubisagari of 1F-07 Parkinson disease Katsumi Kurokawa 1, Shoji Henmi 1, Nana Izawa 2, Garden Masahiro 3, Yoshihide Sunada 1 Neurological Therapeutics 29(5): 629-629, 2012. |
1F-08 L-dopa improves depression of early Parkinson disease Kenichi Kashiwabara, Takaki Imamura Neurological Therapeutics 29(5): 629-629, 2012. |
Association between depressive state and stigma in patients with 1F-09 Parkinson disease Megumi Saruwatari 1, 2, Kazuko Hasegawa 2, Emiko Horiuchi 2, Teruo Yokoyama 2, Public trope 2, Eri Kaneko 2 Neurological Therapeutics 29(5): 630-630, 2012. |
The use situation of zonisamide in 225 1F-10 Parkinson disease and the effect Form Hiroshi Oka, Satoshi Ueno Neurological Therapeutics 29(5): 630-630, 2012. |
It is a hearing impression and a sound analysis the phonic characteristic of patients with 1F-11 spinocerebellar degeneration Makoto Kariyasu 1, Asako Takei 2, Kenichi Fujita 2, Shinsuke Hamada 2, Moriwaka Fumio 2 Neurological Therapeutics 29(5): 630-630, 2012. |
Questionary survey about the rehabilitation to patients with 1F-12 spinocerebellar degeneration 中馬孝容 1, Nimura orthotropic 2, Ryusuke Matsumura 3, Tetsuya Takayanagi 4 Neurological Therapeutics 29(5): 630-630, 2012. |
One case of chronic inflammatory demyelinating multiple neuritis that presented deliriousness by 1G-01 immunoglobulin high dose therapy Jin Suzuki, Seiichi Ono Neurological Therapeutics 29(5): 631-631, 2012. |
The women with 83-year-old CMT1A case which an inflammatory neuropathic merger was suspected in 1G-02 nerve biopsy, and showed an effect by IVIg therapy Aya Naito 1, Kaneji Sekiguchi 2, Old Tomohiro Waku 2, Norio Karita 2, Tatsushi Toda 2 Neurological Therapeutics 29(5): 631-631, 2012. |
67 years old woman of the chronic NK-cell increase symptom that they presented with 1G-03 demyelination-related peripheral neuropathy, and responded to steroid therapy Hiroshi Sano virtue, Toshihiko Maeda, Masatoshi Omoto, Junichi Ogasawara, Michiaki Koga, Kawai former fine weather, Takashi Kanda Neurological Therapeutics 29(5): 631-631, 2012. |
One case that 1G-04 Cyclosporin was effective for a recurrence of chronic inflammatory demyelinating polyradiculoneuritis who had the idiopathic thrombocythemia Akio Kikuchi, Chihiro Suzuki, Tano adults, Vertical mountain Maki, Masaaki Kato, Masashi Aoki Neurological Therapeutics 29(5): 631-631, 2012. |
One case of CIDP which aggravated it by 1G-05 steroid therapy, and was improved by IVIg administration Kaneji Sekiguchi, Takeshi Uenaka, Aya Naito, Old Tomohiro Waku, Norio Karita, Tatsushi Toda Neurological Therapeutics 29(5): 632-632, 2012. |
One case of chronic inflammatory demyelinating multiple neuritis to happen for 1G-06 cervical cancer, and to maintain remission by cancer chemotherapy after an immunoglobulin bolus dose Narumi Nagayama, Kakiuchi no one, Emi Nakanishi, Keiko Tanaka, The Matsui truth Neurological Therapeutics 29(5): 632-632, 2012. |
One case of CIDP(DM-CIDP) merging diabetes that 1G-07 antiHTLV-1 antibody is positive, and responded to steroid-pulse therapy Pail field Yoshihiko, Seiichi Ono Neurological Therapeutics 29(5): 632-632, 2012. |
AntiSGPG antibody-related neuropathic one case where 1G-08 Cyclosporin was effective Kaoru Matsunaga Neurological Therapeutics 29(5): 632-632, 2012. |
72 years old woman case of autoimmune autonomic ganglionopathy which presented with only 1G-09 orthostatic hypotension, and took the chronic course Satoshi Nakae fine weather 1, 城倉健 1, Haruki Koike 2, Sofue former 2 Neurological Therapeutics 29(5): 633-633, 2012. |
Are the antiVEGF monoclonal antibody therapies effective for 1G-10 POEMS syndrome? Sekiguchi relationship, Sonoko Misawa, Shibuya sum trunk, Ayako Nasu, Satsuki between three Tsu, Yudai Iwai, Beach shallows Saki village, Satoshi Kuwahara Neurological Therapeutics 29(5): 633-633, 2012. |
Immunotherapy effect on 1G-11 parainfectious acute autonomous sensory neuropathy Yasushi Kita, Hideo Terasawa, 清水洋孝 Neurological Therapeutics 29(5): 633-633, 2012. |
Clinical features of peripheral neuropathy with 1G-12 HIV infection Rei Kobayashi, Yuzo Hayashi child, Kubo sweetfish incense, Yokoi profound knowledge, Satoshi Okuda, Ei Mukai Ichiro Neurological Therapeutics 29(5): 633-633, 2012. |
Clinical analysis of the t-PA intravenous-injection treatment for the super-acute-phase cerebral infarction in the P01 Okayama University affiliated hospital Shoichiro Kono 1, Kentaro Deguchi 1, Morimoto exhibition one a year, Tomoko Kurata 1, 真邊泰宏 2, Yoshiki Takao 3, Kenichi Kashiwabara 4, Koji Abe 1 Neurological Therapeutics 29(5): 634-634, 2012. |
Two patients who had a relapse of cerebral ischaemia after P02 cerebral infarction t-PA intravenous-injection treatment early Hideo Terasawa, 清水洋孝, Yasushi Kita Neurological Therapeutics 29(5): 634-634, 2012. |
Examination of the cerebroprotection effect by the P03 antiplatelet drug combination 戸田諭補, Laboratory of Katsura Ichiro, 桜澤誠, Takuya Kanemaru, The Shun Inaba east, Moeko Saito, Tairo Katayama Neurological Therapeutics 29(5): 634-634, 2012. |
Investigation about the safety in P04 Dabigatran treated patients Kazuo Yamashiro 1, Ryota Tanaka 1, Your Yasushi Tanaka 2, Yoshiaki Shimada 1, Takuma Kuroki 1, Yuji Ueno 2, Takao Urabe 2, Nobutaka Hattori 1 Neurological Therapeutics 29(5): 634-634, 2012. |
Obese effect on neurologic exacerbation postapoplectic for P05 acute phase Tomoji Kubo 1, 2, Shunsuke Otsuki 2, Naoto Hara 1, Kazuhiro Takamatsu 1, Yasumasa Ota 1, 栗山勝 1, Masayasu Matsumoto 2 Neurological Therapeutics 29(5): 635-635, 2012. |
The restless behavior of the P06 cerebral infarction acute phase and the treatment Hill housekeeping husband 1, Nakano 1, Yuko Kawamoto 1, Idei Fumi 1, Suzuki dream 2 Neurological Therapeutics 29(5): 635-635, 2012. |
It is the fundamental research with the hereditary epilepsy model EL mouse epilepsy treatment by the P07 iteration transcranial magnetic stimulation 由比友顕, 辻貞俊 Neurological Therapeutics 29(5): 635-635, 2012. |
The present conditions of the treatment in the P08 benign adult type family-related myoclonus epilepsy Takeshi Sakurai world 1, Katsuya Kobayashi 1, Takayuki Kondo 1, Takeshi Hitomi sentence 1, 2, Matsumoto law of nature device 1, Ryoho Takahashi 1, Akio Ikeda 1 Neurological Therapeutics 29(5): 635-635, 2012. |
One case of the benign familial myoclonus epilepsy that presented P09 status epilepticus 正崎泰作, Akihiro Tanaka, Tomoko Toyota, 岡田和将, 由比友顕, Naoki Akamatsu, 辻貞俊 Neurological Therapeutics 29(5): 636-636, 2012. |
Use experience of new anticonvulsant levetiracetam in the P10 this hospital Akiko Takeuchi 1, Atsuko Nihei 1, Masahiro Mizobuchi 1, Sako just one 1, Emiko Muramoto 2 Neurological Therapeutics 29(5): 636-636, 2012. |
P11 elderly people epilepsy and levetiracetam Tomoko Toyota, Naoki Akamatsu, Akihiro Tanaka, 正崎泰作, Mitsuhiko Yamano, 辻貞俊 Neurological Therapeutics 29(5): 636-636, 2012. |
Examination about changes from the anticonvulsant of P12 et al. to lamotrigine Emiko Muramoto, Masahiro Mizobuchi, Akiko Takeuchi, Atsuko Nihei, Sako just one, Hirohiko Nakamura Neurological Therapeutics 29(5): 636-636, 2012. |
The 44 years old woman case that developed brain stem thromboembolism due to P13 chronicity tuberculous meningitis Shusaku Omoto 1, Imperial envoy Akihiko Kawahara 1, 星野慈 1, Kaoru Sakimoto University 2, Masaya Hashimoto 1, Masayuki Yoshioka 1, Masahiko Suzuki 1 Neurological Therapeutics 29(5): 637-637, 2012. |
One case of meningitis due to Campylobacter fetus in acknowledgment of cerebrospinal fluid findings of the P14 polynuclear ball predominance Yasuhiro Nagashima, Kazuhiro Muramatsu, Naoko Ogura, Jun Goto, Michiyuki Maruyama Neurological Therapeutics 29(5): 637-637, 2012. |
Safety of the carbapenem-based antimicrobial agent in the P15 acute meningitis Hiroko Teramoto, Akihiko Morita, Makoto Hara, Kazuaki Ichihara, Naoto Taira, South Masayuki, Mai Yamaguchi, Keiko Takahashi, Satoshi Kamei Neurological Therapeutics 29(5): 637-637, 2012. |
One case of the cryptococcal meningoencephalitis that had difficulty in recurrence and differentiation of the P16 neuro-Behcet disease Kosuke Fukuhara, Akira Yokote, Satoshi Kimura, Jun Tsugawa, Yoshio Tsuboi Neurological Therapeutics 29(5): 637-637, 2012. |
Treatment of the cryptococcus meningitis complicated with P17 HIV infection Yuzo Hayashi child 1, Kubo sweetfish incense 1, Ei Mukai Ichiro 1, Junji Imamura 2, Yokomaku ability line 2, Rina Hashimoto 3 Neurological Therapeutics 29(5): 638-638, 2012. |
2 cases that P18 P-ANCA positive caused bilateral otitis media and facial diplegia, and was given immunosuppressive therapy Plains having fun 1, Taku Hatano 1, Yasuyuki Okuma 2, Nobutaka Hattori 1 Neurological Therapeutics 29(5): 638-638, 2012. |
It is examination about the course of the bilateral GPi-DBS treatment for the DYT1 case of 30 years after the P19 onset Yoko Sunami 1, Fusako Yokochi 1, Makoto Taniguchi 2, Ryoichi Okiyama 1, Kimura mere child 2, 伊藤博崇 2, Yasuko Aoki 1, Takashi Kawasaki 2, Koichi Hamada 2 Neurological Therapeutics 29(5): 638-638, 2012. |
One case of Benign tremulous parkinsonism where P20 deep brain stimulation was effective Jiro Fukae 1, Fukaya parent 2, Yoichi Katayama 2, Nobutaka Hattori 3 Neurological Therapeutics 29(5): 638-638, 2012. |
One case of the tardive dystonia that P21 brain depth stimulation therapy was effective Spring water harmony, reverence, purity and tranquility, Yoko Sunami, Fusako Yokochi Neurological Therapeutics 29(5): 639-639, 2012. |
One case of Parkinson disease that syncopal attack that P22 paroxysmal atrial fibrillation was given catheter ablation therapy and was repeated improved Akira Yokote 1, 2, Kosuke Fukuhara 2, Jun Tsugawa 2, Yoshio Tsuboi 2 Neurological Therapeutics 29(5): 639-639, 2012. |
Fixed-quantity analysis of the ECT effect of treatment for Parkinson disease with psychiatric symptoms of the P23 severeness Kennya Nishioka 1, Hideki Shimura 2, Nobutaka Hattori 1, Takao Urabe 2 Neurological Therapeutics 29(5): 639-639, 2012. |
gating abnormality before self-pace motion of cortex SEP in P24 Parkinson disease Katsuya Ogata, Hagiwara rope one, Tobimatsu Shozo Neurological Therapeutics 29(5): 639-639, 2012. |
New severity scale MG composite of P25 myasthenia gravis Masayuki Masuda 1, Spear swamp New Komeito 2, Shigeaki Suzuki 3, Yuriko Nagane 2, Yasushi Suzuki person 5, Yuko Shimizu 4, Hironari Utsumi 1, Kazuo Fujiwara 6, Shinichiro Uchiyama 4, Norihiro Suzuki 2 Neurological Therapeutics 29(5): 640-640, 2012. |
Histories of treatment of the last part of P26 senile-onset systemic type myasthenia gravis 3 case Nakano 1, Hill housekeeping husband 1, Yuko Kawamoto 1, Suzuki dream 2 Neurological Therapeutics 29(5): 640-640, 2012. |
P27 50 years old or older until clinical picture -64 years old in onset myasthenia gravis vs 65 years old or older - Kazuka Sakai 1, 2, Naoko Matsui 2, Izumi mere sincerity 2, 梶龍兒 2 Neurological Therapeutics 29(5): 640-640, 2012. |
61 years old man case of the polymyositis that the treatment resistance responded to two times of gamma globulin high dose therapy to P28 steroid, an immunosuppressive drug Satoshi Ota University, Tomoaki Kumagai, Yutaka Nagayama, Mineo Yamazaki, Tairo Katayama Neurological Therapeutics 29(5): 640-640, 2012. |
Acute for P29 respiratory failure; occur; one case with suspected myofibrillar myopathy Akira Taniguchi, Yuichiro Ii, Tomimoto Hidekazu Neurological Therapeutics 29(5): 641-641, 2012. |
Examination of the nutritional requirement estimation method of patients with neuromuscular disorders using the P30 double energy X-ray absorption method Tsuyoshi Matsumura, Forest 1,000 daylight, Keiko Toyooka, 藤村晴俊, Sako field Saburo Neurological Therapeutics 29(5): 641-641, 2012. |
55 years old woman case of the pure autonomic nerves deficiency that pyridostigmine was effective for syncope reduction due to P31 orthostatic hypotension The Terada truth, Koji Tomidokoro, Akira Tamaoka Neurological Therapeutics 29(5): 641-641, 2012. |
72 years old man case of meningeal carcinomatosis that responded to P32 ventriculoperitoneal shunting Tomoaki Kumagai, Satoshi Ota University, Yutaka Nagayama, Mineo Yamazaki, Tairo Katayama Neurological Therapeutics 29(5): 641-641, 2012. |
1 case of Episodic spontaneous hypothermia with hyperhidrosis (following, ESHH) where P33 Cypropheptadine was effective Juri Hasegawa, Kazuhiro Endo Neurological Therapeutics 29(5): 642-642, 2012. |
One case of mitochondrial myopathy with episodic hyper-creatine kinase-emia(MIMECK) where P34 L-arginine was effective Field wife Satoshi, 橋口昭大, Hirotsugu Okamoto, Way garden Kumiko, It is still Kotobuki an exit, Itsuro Higuchi, Hiroshi Takashima Neurological Therapeutics 29(5): 642-642, 2012. |
One case of the elderly men who presented with serotonin syndrome by sertraline and tandospirone of the P35 small quantity Kenichi Kawada, Kiyomi Oodate Neurological Therapeutics 29(5): 642-642, 2012. |
One case that was regarded as the leptomeninx origin malignant lymphoma that showed a clinical examination not to contradict it for P36 tuberculous meningitis and effect of treatment Taguchi Sotaro, Keisuke Tokui, Junichi Niwa, Akihiro Yasumoto, Koji Nakajima, Tomoko Yuasa, Tomoko Nishikawa, 田邉奈千, Yuka Tsunoda, Yuko Ichikawa, Fujikake Akifumi, Takashi Fukuoka daylight, Spring Masayuki, Naoki Nakao, 道勇学 Neurological Therapeutics 29(5): 642-642, 2012. |
Action to treatment at home for the P37 neurologic disease The Sugiura truth, Tetsuro Ando Neurological Therapeutics 29(5): 643-643, 2012. |
About an effect and the safety of the automatic aspiration system by the P38 double suction Yoshiaki Urano, Mieko Ogino, Akiko Uchino, Eiji Kitamura, Saori Miyakawa, Makiko Nagai Neurological Therapeutics 29(5): 643-643, 2012. |
Safe examination of the ramelteon lock for the sleep of P39 spinocerebellar degeneration (mela-tonin receptor agonist) Nail book Chiharu, Hiroshi Doi, Suzuki dream, Junichi Hirata, Yasuko Tomita, Kubota eyewink Neurological Therapeutics 29(5): 643-643, 2012. |
Histories of treatment of the primary central nervous system malignant lymphoma with the P40 large quantities methotrexate therapy Doden is regular, Takao Hashimoto Neurological Therapeutics 29(5): 643-643, 2012. |
Examination of cerebroprotection effects of nicergoline in the P41 rat arteria cerebri media eternal obstructing model Chikako Nito, The Shun Inaba east, Masayuki Ueda, Fumio Kamiya, Tomonari Saito, Tairo Katayama Neurological Therapeutics 29(5): 644-644, 2012. |
Fundamental researches about neuropathic pain treatment by the P42 iteration transcranial magnetic stimulation 由比友顕, 辻貞俊 Neurological Therapeutics 29(5): 644-644, 2012. |
P43 Usefulness of [Mograz] (ADHD Test Program) in Alzheimer's disease diagnosis 磯野千春, 中村雄作, 阪本光, 上野周一, 平野牧人 Neurological Therapeutics 29(5): 644-644, 2012. |
Use experience of rivastigmine (patch) for P44 Alzheimer disease Sei Matsui Expo, Nao Takenaka, Satoshi Matsuya, Kenta Matsubara, Makiko Hashimoto, Toshiyuki Yamanishi, Depths Tomoko, Daisuke Maruno, Keita Kawabata, Hisashi Tachibana University Neurological Therapeutics 29(5): 644-644, 2012. |
Investigation about the prognosis of patients with amyotrophic lateral sclerosis in the P45 Chiba east kudzu northern part 高橋澄加 2, Tadashi Kurita 1, 梁取彗 2, Toshiaki Hirai 1 Neurological Therapeutics 29(5): 645-645, 2012. |
Examination of 274 patients with motor neurone disease in the P46 Okayama University Hospital neurology 佐藤恒太, The Morimoto exhibition year, Tomoko Kurata, Yasuyuki Ota, Kentaro Deguchi, Ikeda Kei life, Toru Matsuura, Koji Abe Neurological Therapeutics 29(5): 645-645, 2012. |
Utility of SEIQoL-DW in the quality of life evaluation of patients with P47 neurodegenerative disease Hiroki Watanabe 1, Hisashi Ito 2, Great quantity lawn seedling 2, Toru Kamei original 2 Neurological Therapeutics 29(5): 645-645, 2012. |
The P48 local government public information paper is effective as a method of the headache enlightenment in the remote place It is still 1 light wisteria, 2, Fumio Yamamoto 1, Yasuyuki Ito 1, Seiichi Mizumoto 3, Toshimasa Yamamoto 2, Nobuo Araki 2 Neurological Therapeutics 29(5): 645-645, 2012. |
Use experience of the new anticonvulsant for the adults with intractable epilepsy case from the P49 childhood 竹内千仙, Yoko Mochizuki Neurological Therapeutics 29(5): 646-646, 2012. |
One case of the limbic encephalitis with the chemical hypersensitivity syndrome by P50 Carbamazepine 宇本麻衣子 1, Kajimoto justice 2 to congratulate, Hideto Miwa 1 Neurological Therapeutics 29(5): 646-646, 2012. |
One case of the temporal lobe epilepsy that the contribution of the P51 antiVGKC complex antibody was thought about Tomoko Toyota 1, Naoki Akamatsu 1, Akihiro Tanaka 1, 正崎泰作 1, 辻貞俊 1, Ayumu Uchibori 2, Osamu Watanabe 3, Yukitoshi Takahashi 4 Neurological Therapeutics 29(5): 646-646, 2012. |
Action - in importance - this hospital of the neurologist concerned with P52 epilepsy surgery of 18 years Mitsuhiko Yamano 1, Naoki Akamatsu 1, Akihiro Tanaka 1, 4, 正崎泰作 1, Tomoko Toyota 1, Mayu Takahashi 2, Masayuki 3 who resigns from the post, 西澤茂 2, 辻貞俊 1 Neurological Therapeutics 29(5): 646-646, 2012. |
Treatment of the P53 late onset epilepsy Akihiro Tanaka 1, 2, Naoki Akamatsu 1, 正崎泰作 1, Tomoko Toyota 1, Mitsuhiko Yamano 1, Nakagawa teachings of Buddha 2, 辻貞俊 1 Neurological Therapeutics 29(5): 647-647, 2012. |
One case of the non-convulsive status epilepticus of the old onset which responded to P54 Phenobarbital IV infusion Masako Tanaka, Completion Keiko, 正崎泰作, Tomoko Toyota, 由比友顕, 岡田和将, Naoki Akamatsu, 辻貞俊 Neurological Therapeutics 29(5): 647-647, 2012. |
One case of the Bickerstaff type brainstem encephalitis that responded to P55 IVIg+ steroid-pulse therapy Megumi Mori 1, Kajimoto justice 1 to congratulate, 宇本麻衣子 2, Hideto Miwa 2 Neurological Therapeutics 29(5): 647-647, 2012. |
Examination of the background factor of encephalomyelitis that a response lacks in P56 steroid-pulse therapy Takashi Sugiyama, Tsuyoshi Uchiyama, Tomoyasu Takeuchi, Daisuke Yamamoto, Kei Sato Shiro, Takako Shimizu, Toshihiko Ohashi Neurological Therapeutics 29(5): 647-647, 2012. |
One case of the anti-aquaporin-4 antibody-positive neuromyelitis optica that P57 steroid-pulse therapy combination immune adsorption therapy was effective Takeshi Yamada, The Kawashiri truth sum Neurological Therapeutics 29(5): 648-648, 2012. |
Clinical analysis of the neuromyelitis optica treated effectively with P58 double filtration plasma skimming exchange 仙石錬平, 宮川晋治, Shusaku Omoto, Satoshi Takagi, Hideki Mimura, Masayo Morita, 持尾聰一郎 Neurological Therapeutics 29(5): 648-648, 2012. |
One case of the neuromyelitis optica that combination of P59 intermittent intravenous immune globulin therapy and azathioprine was effective for long-term prevention of recurrence 岡田和将, Utako Takechi, Line oneself man out of the rock, 辻貞俊 Neurological Therapeutics 29(5): 648-648, 2012. |
P60 Tacrolimus is the analysis using the transcranial magnetic stimulation method one case of the effective Stiff-person syndrome Utako Takechi 1, 岡田和将 1, Kaoru Matsunaga 2, 辻貞俊 1 Neurological Therapeutics 29(5): 648-648, 2012. |
Measure of the apathy in patients with P61 Parkinson disease Public trope 1, Fumie Saito 2, Gen Kato Ichiro 2, Akira Matsunaga Kei 3, Noriko Kawashima 3, Eri Kaneko 1, Kazuko Hasegawa 1 Neurological Therapeutics 29(5): 649-649, 2012. |
Intervention to the memory function of patients with P62 Parkinson disease Eri Kaneko, Public trope, Megumi Saruwatari, Emiko Horiuchi, Teruo Yokoyama, Kazuko Hasegawa Neurological Therapeutics 29(5): 649-649, 2012. |
73 years old man case of Parkinsonism by bilateral chronic subdural hematoma (CSDH) cured by conservative treatment by the P63 wu-ling-san Hidetomo Murakami 1, 2, Masayuki Sugie 2, Hiroki Shimizu 2, Kamiya male oneself 2, Hisashi Masaki 2, Hiroo Ichikawa 2, Mitsuru Kawamura 1 Neurological Therapeutics 29(5): 649-649, 2012. |
An effect on Parkinson disease with dementia of P64 Donepezil HCl 10 mg/day and safe examination Keiichi Ishikawa 1, Yumiko Motoi 1, 2, Nobutaka Hattori 1 Neurological Therapeutics 29(5): 649-649, 2012. |
Four cases of the advanced Parkinson's syndrome that '"clenched fist" which P65 `grip included had Jin Abe period, North Fumiko Neurological Therapeutics 29(5): 650-650, 2012. |
Examination of the neuroprotection effect of zonisamide in the P66α- synuclein expression rat model 荒若繁樹, 加藤丈夫 Neurological Therapeutics 29(5): 650-650, 2012. |
One patient who received treatment (VMP therapy) that increased bortezomib for P67 POEMS syndrome Araki lap 1, Jun Hashizume 1, Haruki Koike 1, 渡辺宏久 1, Shigeru Saito period 2, Sofue former 1 Neurological Therapeutics 29(5): 650-650, 2012. |
Examination of an injection method and the effect of treatment of the immunoglobulin large quantities intravenous-injection treatment in P68 CIDP 飯嶋一侑樹 1, Kei Goto dawn 1, Takashi Yasuda 1, Kentaro Tokuoka 1, It is still 1 Takeshi Okuma, Yasuhisa Kitagawa 1, Toshiya Takizawa 2 Neurological Therapeutics 29(5): 650-650, 2012. |
One case that P69 Isaacs syndrome was diagnosed, and plasmapheresis was effective, but presented progressive bilateral feet muscle weakness Ai Miyagi, Takashi Furukawa University, Koichiro Taniguchi, Shimatani Kei light, Koji Fujita, Izumi mere sincerity, 梶龍兒 Neurological Therapeutics 29(5): 651-651, 2012. |
One case that presented demyelinating polyneuropathy approximately 4.5 years after P70 Infliximab induction Keiko Nakamura 1, Daisuke Noto 1, Tsuyoshi Hamaguchi 1, Yoshiko Hamano 2, 楫野良知 3, Seiji Yamada 1 Neurological Therapeutics 29(5): 651-651, 2012. |
P71 brothers case of the Charcot-Marie-Tooth illness that responded to gamma globulin therapy in large quantities 船水章央 1, Rie Haga 1, Yasuo Miki 1, Chieko Suzuki 1, Tomohiko Tomiyama 1, Masayuki Baba 1, Ai Kurihara Ichiro 2, 橋口昭大 3, Hiroshi Takashima 3 Neurological Therapeutics 29(5): 651-651, 2012. |
Severe case of the multifocal motor neuropathy during long-term remission by P72 Uromitexan bladder perfusion combination cyclophosphamide large quantities intravenous-injection treatment Eri Iwasawa 1, Takuya Okubo 1, 叶内匡 2, 冨滿弘之 3, Takanori Yokota 1, 水澤英洋 1 Neurological Therapeutics 29(5): 651-651, 2012. |
Examination about 2 cases of P73 adults onset type II citrullinemia (CTLN2) Ryota Tanaka, Nobutaka Hattori Neurological Therapeutics 29(5): 652-652, 2012. |
One case that presented unilateral dance exercise by P74 polycythaemia vera Measure field very much straight 1, Akira Furukawa I 2, Takashi Ito will 1, Tsuyoshi Fukushima 1, Shigeyuki Kojima 1 Neurological Therapeutics 29(5): 652-652, 2012. |
One case of Posterior reversible encephalopathy syndrome(PRES) secondary to P75 motion inducibility renal failure Keiko Takahashi 1, Mai Yamaguchi 1, Akihiko Morita 1, Hiroshi Shiota 1, Satoshi Kamei 1, Masayoshi Soma 2, 3 Neurological Therapeutics 29(5): 652-652, 2012. |
23 times of inpatient care experience in P76 MELAS four Crossroads river Koyo, Kuniyuki Endo, Daisuke Ito, Makoto Hattori, 仁紫了爾, Kazuya Kawahata, Shinichiro Yamada, Noriyoshi Nakai, Keizo Yasui, Yasuhiro Hasegawa Neurological Therapeutics 29(5): 652-652, 2012. |
Occur for P77 easy fatigability, a muscle ache; the histories of treatment of the mitochondrial illness 19 years old woman case with the T3271C point mutation Yasuko Kuroba 1, 松原奈絵 1, Yuka Hasegawa 1, Valley table 1, Other fields truth 2, Izumi Kochi 2, Masatoyo Nishizawa 2, Akiko Koike 1 Neurological Therapeutics 29(5): 653-653, 2012. |
Examination of the medical treatment for the P78 chronicity intestinal pseudo-obstruction Naomi Mamata, Koji Tomidokoro, Akiko Ishii, Akira Tamaoka Neurological Therapeutics 29(5): 653-653, 2012. |
26 years old man case of acute polyradiculitis that presented 3B-01 face, cochlea neuroparalysis, orthostatic hypotension, hyponatremia Takashi Takasawa period, Ken Ikeda, 平山剛久, Kiyoko Murata, Seiichi Kawabe, Yasuo Iwasaki Neurological Therapeutics 29(5): 654-654, 2012. |
One case of peripheral neuropathy that 3B-02 immunoglobulin large quantities intravenous-injection treatment (IVIg) was effective, and multiple lesions were found in in cerebral white matter Hirotsugu Mikami, Seiichi Ono Neurological Therapeutics 29(5): 654-654, 2012. |
One case of the severe Guillain-Barre syndrome that 3B-03 immunoglobulin large quantities intravenous-injection treatment was invalid, and was treated effectively with a plasma exchange Takayuki Kosaka 1, 米持康寛 1, Kozaki Yanosuke 1, Tomohiro Takita 1, 俵哲 1, Kengo Kajiwara 2, Masao Tomita 2 Neurological Therapeutics 29(5): 654-654, 2012. |
One patient who presented with unilateral external ophthalmoplegia of the 3B-04 antiGQ1b antibody positive and appendicular dysesthesia, and was treated effectively with immune adsorption therapy for external ophthalmoplegia Miyake Akifumi, Toshimasa Yamamoto, Light wisteria still, Takahiro Sasaki, Yoshihiko Nakazato, Nobuo Araki Neurological Therapeutics 29(5): 654-654, 2012. |
One case of acute autonomic and sensory neuropathy(AASN) where good course was obtained by 3B-05 steroid therapy Mari Kitada 1, Juri Ichihashi 1, Hidekazu Suzuki 1, Yoshinobu Mitsui 1, 楠進 1, Nobuyuki Oka 2 Neurological Therapeutics 29(5): 655-655, 2012. |
Effect of pregabalin on autonomic nervous system disorders of the 3B-06 Guillain-Barre syndrome acute phase Kuroda sky 1, Nihiko Kaneko 1, Yoshida falcon 1, Ichiro Nakajima 1, Vertical mountain Maki 1, 楠進 2, Kazuo Fujiwara 1, Masashi Aoki 1 Neurological Therapeutics 29(5): 655-655, 2012. |
One case of the non-eosinophilic fasciitis that presented with 3B-07 muscle weakness, and showed a neurogenic change in muscle biopsy Hiroaki Ishikawa, Seiichi Ono Neurological Therapeutics 29(5): 655-655, 2012. |
One case of Progressive encephalomyelitis with rigidity(PER) where we showed improvement in the symptom by 3B-08 thymomectomy Shimada under-secretary, Rei Kobayashi, Hisashi Okada, Satoshi Okuda, Ei Mukai Ichiro Neurological Therapeutics 29(5): 655-655, 2012. |
It is two patients of the chronic graft-versus-host disease after the allogeneic marrow transplantation that resulted in 3B-09 skeletal muscle symptom Shinichi Shirai, An upper floor still, Hiroaki Nishimura, 佐久嶋研, 廣谷真, 加納崇裕, Ichiro Yabe, Hidenao Sasaki Neurological Therapeutics 29(5): 656-656, 2012. |
One case of skeletal muscle type pole long-chain acyl-coenzyme A dehydrase (VLCAD) deficiency which presented acute heart failure for 3B-10 puerperal period 村田顕也 1, Hideo Sugie 2, Nishino Ichizo 3, Hideto Miwa 1, Tomoyoshi Kondo 1 Neurological Therapeutics 29(5): 656-656, 2012. |
Muscular dystrophy treatment by the muscle reproduction ornamentation using mesenchymal stem cells derived from 3B-11 marrow framework Yasushi Maeda 1, Masatoshi Ishizaki 2, Asuka Koga 1, Yuki Ando male 1 Neurological Therapeutics 29(5): 656-656, 2012. |
The prospects to medical treatment of the skeletal muscle phthisis with the 3B-12 small molecule TβRI kinase inhibitor 大澤裕, 力丸満恵, 砂田芳秀 Neurological Therapeutics 29(5): 656-656, 2012. |
60 years old man case of the central pontine myelinolysis that occurred all over the course of 3B-13 pancreatic diabetes Hirochika Kuwahara 1, Shinichi Matsunaga 2 Neurological Therapeutics 29(5): 657-657, 2012. |
69 years old man case of diabetes that complicated central pontine myelinolysis after recovery of 3B-14 non-alcoholicity Wernicke encephalopathy Ken Ikeda 1, Kishimoto shifts and changes 2, Kiyoko Murata 1, Seiichi Kawabe 1, Osamu Kano 1, Yasuo Iwasaki 1 Neurological Therapeutics 29(5): 657-657, 2012. |
One patient who complicated hyperglycemic chorea and cerebellum incontinence during treatment of 3B-15 antiGAD antibody-positive type I diabetes mellitus Jin Arata 1, Kazuya Shinohara 1, Temple place connection 2, Way garden Kumiko 1, Kenichi Ikeda 1, It is still 2, Kotobuki an exit, Hiroshi Takashima 1 Neurological Therapeutics 29(5): 657-657, 2012. |
Examination of the prognostic factor in 3B-16 hypoglycemia encephalopathy 下畑享良 1, Tetsuhiko Ikeda 1, Tetsuya Takahashi 1, Akira Sato 2, Shuichi Igarashi 2, Takeo Kuwahara 3, Masatoyo Nishizawa 1 Neurological Therapeutics 29(5): 657-657, 2012. |
One case that presented respiratory failure by hypokalemic myopathy with the poor 3B-17 caloric intake Makoto Nomura, Seiichi Ono Neurological Therapeutics 29(5): 658-658, 2012. |
One case of Wilson's disease that showed head MRI and significant improvement of the SPECT by 3B-18 Zinc acetate monotherapy Ishida will hilum 1, 土居芳充 1, Uno field Kiichi 1, Kazushi Yamane 1, Takashi Hosokawa 1, Hideto Nakajima 1, Bunji Kimura 1, Hiroshi Tamai 2 Neurological Therapeutics 29(5): 658-658, 2012. |
Red urine improved by 3B-19 drug adjustment remarkably, one case of the acute porphyria without the stomachache Sinter garden daylight, Yoshiko Takeda, Tadashi Matsuda purely, 菅原正伯 Neurological Therapeutics 29(5): 658-658, 2012. |
One case of cerebrotendinous xanthomatosis that responded to 3B-20 Chenodeoxycholic acid, LDL - apheresis and rosuvastatin combined treatment 新村浩透, Waterfall shallows Yasuhiro, Shinji Hirose, 菊池雷太, Kiyomi Nanun Neurological Therapeutics 29(5): 658-658, 2012. |
Histories of treatment of cerebrotendinous xanthomatosis that we were able to diagnose from Achilles' tendon hyperplasia in acknowledgment of 3B-21 intellectual impairment, a cerebellar syndrome Masuda pen name, Jun Hashizume, 伊藤瑞規, Naoki Atsuta, 渡辺宏久, Origin of Sofue Neurological Therapeutics 29(5): 659-659, 2012. |
One case of Hashimoto encephalopathy that showed 3B-22 significant cerebellar atrophy, and required a variety of immunotherapy Way garden Kumiko 1, Miwa Nomura 1, Jin Arata 1, It is still 2, Kotobuki an exit, Ryoji Takada 1, Hiroshi Takashima 1 Neurological Therapeutics 29(5): 659-659, 2012. |
One case of progressive encephalomyelitis with rigidity treated effectively with 3B-23 steroid Noriko Nishikawa, Yutaka Iwaki still, Tomoaki Tsujii, Masahiro Nagai, Masahiro Nomoto Neurological Therapeutics 29(5): 659-659, 2012. |
One case of encephalopathy with the Sjogren syndrome which presented clinical condition of the 3B-24 Creutzfeldt-Jakob disease resemblance 松尾宏俊 1, Fujii Chihiro 1, 2, Toshiki Mizuno 2, Nakagawa teachings of Buddha 2 Neurological Therapeutics 29(5): 659-659, 2012. |
3B-25 Study by collective cognitive function tests (Five cog test) of the effects of dementia prevention classroom in the general elderly 瀬川文徳 Neurological Therapeutics 29(5): 660-660, 2012. |
Effect to give to a cognitive function of imidafenacin in the 3B-26 overactivity bladder patients Takatsugu Sakakibara 1, 成本迅 2, Fuyuki Tateno 1, Osamu Takahashi 3, Tomoyuki Uchiyama 4, Tatsuya Yamamoto 4, Awa Yusuke 5, Tomonori Yamanishi 6, Chiharu Yamaguchi 6, Masahiko Kishi 1, Yohei Tsuyusaki 1 Neurological Therapeutics 29(5): 660-660, 2012. |
3 cases of the idiopathic cerebrospinal fluid hypovolemia that hearing loss improved by 3B-27 treatment Shinichiro Yamada 1, Masashi Tsujimoto 2, Keizo Yasui 1, Yasuhiro Hasegawa 1 Neurological Therapeutics 29(5): 660-660, 2012. |
About efficacy and problems of the intraspinal baclofen therapy in the 3B-28 nerves intractable disease (the second report) Masanobu Mizuno 1, Yasumasa Nishikawa 2, Kanako Kato 1, Kazumasa Oura 1, Yasuo Terayama 1, Naoki Ishizuka 3 Neurological Therapeutics 29(5): 660-660, 2012. |
Utility of myelography and the CT myelography at treatment preferences for 3B-29 spinal disease and the similar disease Hineno Akiyo, 吉田拓弘, Kazuhiro Fukushima, Shuichi Ikeda Neurological Therapeutics 29(5): 661-661, 2012. |
39 years old woman case of acromelalgia that 3B-30 immunoglobulin high dose therapy was effective Takeshi Kuroda, Seiichiro Ishigaki, Sugimoto Azusa, Mitsuru Kawamura Neurological Therapeutics 29(5): 661-661, 2012. |
Efficacy of the steroid therapy in the systemic adiaphoresis born after 3B-31 idiopathy Masato Asahina, Fujinuma Yoshikatsu, 山中義崇, Akira Katagiri, Anupama Poudel, Satoshi Kuwahara Neurological Therapeutics 29(5): 661-661, 2012. |
Two cases of finger muscle weakness that muscular strength improved by the electromagnetic stimulation method (TMS with MVC) at the 3B-32's greatest muscle contraction Tetsuo Toge 1, Urai reason light 2, Kume immensity 2, Kazuyo Ikeda 2, Kazushi Deguchi 2, Masanori Kamata 3 Neurological Therapeutics 29(5): 661-661, 2012. |
The medical cooperation situation according to the ischemic cerebrovascular disease clinic form in 3C-01 Kumamoto Yasuyuki Ito 1, Straw bag wish 1, Fumio Yamamoto 1, Yoichiro Hashimoto 1, Shuji Terasaki 2 Neurological Therapeutics 29(5): 662-662, 2012. |
It is ... about a utility of ... high minute interactive Electronic Information Exchange System for telestroke induction suitable for a dish simmered in medical environment of the 3C-02 our country Kenzo Sakurai, Isa early Kenji, Takeshi Imai, 白石眞, Yasuhiro Hasegawa Neurological Therapeutics 29(5): 662-662, 2012. |
From the questionnaire for factor - non-specialist that Hub, Spoke institution at the 3C-03 Telestroke induction should coordinate it Isa early Kenji 1, Kenzo Sakurai 2, Takeshi Imai 2, Yasuhiro Hasegawa 2 Neurological Therapeutics 29(5): 662-662, 2012. |
Adoption, the use situation of dabigatran in 3C-04 convalescence, the maintenance phase institution Shuji Terasaki 1, Yoichiro Hashimoto 2, Toshiro Yonehara 3 Neurological Therapeutics 29(5): 662-662, 2012. |
The factor which is related to the prolongation of the ratio in an aPTT after the dabigatran internal use in patients with 3C-05 cerebrovascular disorder Takuya Okada 1, Miyashita under-secretary 1, Masato Osaki 1, Long bunch party 2, Kazuo Minematsu 1, Kazunori Toyota 1 Neurological Therapeutics 29(5): 663-663, 2012. |
One case of RCVS where we occurred in a row in 3C-06 vertebral arterial dissection, and treatment around verapamil was effective Takeshi Oyama, Araki lap, Naoki Atsuta, 渡辺宏久, Origin of Sofue Neurological Therapeutics 29(5): 663-663, 2012. |
3C-07 Effect of fasudil on the expression middle cerebral artery occlusion model rat brain aquaporin 4, 9[Machine Translation] (中大脳動脈閉塞モデルラット脳内アクアポリン4, 9発現に及ぼすfasudilの効果) Sheikh Abdullah1, 長井篤1, 王暉2, 石橋豊3, 梁雪云1, 三瀧真悟2, 矢野彰三1, 小林祥泰4, 山口修平2 Neurological Therapeutics 29(5): 663-663, 2012. |
It is examined the efficacy of the oral administration after ischemia of atorvastatin in the 3C-08 rat transient local cerebral ischaemia model Tomonari Saito, Chikako Nito, Masayuki Ueda, The Shun Inaba east, Fumio Kamiya, Tairo Katayama Neurological Therapeutics 29(5): 663-663, 2012. |
Examination of the cerebroprotection effect with the ibudilast premedication in the 3C-09 rat transient cerebral ischemia model Nobuo Kamiya, Masayuki Ueda, The Shun Inaba east, Tairo Katayama Neurological Therapeutics 29(5): 664-664, 2012. |
Examination of the effect on vascular endothelium, Rho- kinase activation of the EPA-E premedication in the 3C-10 rat local cerebral ischaemia model Masayuki Ueda, Chikako Nito, Fumio Kamiya, Tomonari Saito, Nobuo Kamiya, Tairo Katayama Neurological Therapeutics 29(5): 664-664, 2012. |
3C-11 Argatroban(ARB) high-dose therapy about a principle and a therapeutic dose: Hiroaki Ishibashi Neurological Therapeutics 29(5): 664-664, 2012. |
Examination of CAVI(cardio ankle vascular stiffness index) in patients with 3C-12 Parkinson disease Jun Suzuki 1, Takatsugu Sakakibara 2, Mina Yamada 1, Megumi Sugiyama 1, Tsuyoshi Ogawa 1, Takumi Kurosu 1, Fuyuki Tateno 2, Yohei Tsuyusaki 2, Masahiko Kishi 2, Koji Shirai 2, East circle your letter 1 Neurological Therapeutics 29(5): 664-664, 2012. |
3C-13 normal pressure hydrocephalus Shunt postoperative dysuria improvement and frontal lobe increased vascular flow Takatsugu Sakakibara 1, Yoshitaka Uchida 2, Fuyuki Tateno 1, Masahiko Kishi 1, Yohei Tsuyusaki 1, Osamu Takahashi 3, Megumi Sugiyama 3, Tomoyuki Uchiyama 4, Tatsuya Yamamoto 4, SIN PHONI5 Neurological Therapeutics 29(5): 665-665, 2012. |
Comparison with examination - Alzheimer disease by hollow dynamics of the 3C-14 blood vessel-related urinary incontinence Takatsugu Sakakibara 1, Fuyuki Tateno 1, Masahiko Kishi 1, Yohei Tsuyusaki 1, Tsuyoshi Ogata 1, Hatta Hiroyuki 1, Osamu Takahashi 2, Megumi Sugiyama 2, Tomoyuki Uchiyama 3, Tatsuya Yamamoto 3 Neurological Therapeutics 29(5): 665-665, 2012. |
The blood glucose pattern of patients with acute ischemic stroke with the 3C-15 continuation blood glucose measuring instrument and clinical symptom Junichi Uemura, 下山隆, Takashi Shiromoto, Kenichiro Sakai, Junnya Aoki, 山下眞史, Ken Shibasaki product, Tsuyoshi Inoue, Yasuyuki Iguchi, Kazumi Kimura Neurological Therapeutics 29(5): 665-665, 2012. |
Characteristic of patients with cerebral hemorrhage that received blood glucose scale management for 3C-16 acute phase Hayato Matsushima 1, 有廣昇司 2, Masatoshi Koga 2, Satoshi Shimomura 1, Akiko Ishigami 1, Kazuo Minematsu 1, Kazunori Toyota 1 Neurological Therapeutics 29(5): 665-665, 2012. |
Acute care of 3C-17 hypervolemia-related cerebral infarction and outcome Kubo sweetfish incense 1, Satoshi Okuda 1, Ei Mukai Ichiro 1, Haruhiko Ohashi 2 Neurological Therapeutics 29(5): 666-666, 2012. |
A clinical picture of 3C-18 acute microcerebral hemorrhage and remedial discussion Masao Nagayama 1, 2, 梁成勲 1, 2, Hisashi Kitagawa true 2, Shiozawa Masaji 1, 2 Neurological Therapeutics 29(5): 666-666, 2012. |
Examination of the rectal bleeding in the 3C-19 ischemic stroke acute phase Yukiko Suzuki, Hiroyuki Kawano, Yuichiro Inatomi, Toshiro Yonehara Neurological Therapeutics 29(5): 666-666, 2012. |
The examination of the posture of the sleep-disordered breathing in the 3C-20 stroke acute phase and application to a sideways-facing pillow Junichi Uemura, Kure shop Yoshino, Kenichiro Sakai, Junnya Aoki, 山下眞史, Naoki Saji, Ken Shibasaki product, Tsuyoshi Inoue, Yasuyuki Iguchi, Kazumi Kimura Neurological Therapeutics 29(5): 666-666, 2012. |
Examination of the acute phase stroke case that became the antiplatelet drug combination therapy at a 3C-21 discharge Haruhiko Hoshino 1, Chiaki Arakawa 1, Saori Moriya 1, Tomohide Adachi 1, Makoto Takagi 1, 伊藤義彰 2, Norihiro Suzuki 2 Neurological Therapeutics 29(5): 667-667, 2012. |
New dementia BPSD score suitable for 3D-01 modern Japan Koji Abe, Tomoko Kurata, 佐藤恒太, Kentaro Deguchi, Toru Yamashita, Ikeda Kei life Neurological Therapeutics 29(5): 668-668, 2012. |
Utility of "Attended alone" sign in the 3D-02 forgetfulness practice Toshio Fukutake Neurological Therapeutics 29(5): 668-668, 2012. |
Comparison of donepezil and the galantamine administration example for patients with Alzheimer type dementia in the 3D-03 Okayama University Hospital neurology 佐藤恒太, Tomoko Kurata, Yasuyuki Ota, Masami Ikeda, Shoichiro Kono, Kentaro Deguchi, Shoko Deguchi, Ikeda Kei life, Tortoise Satsuki Ko, Muraoka ten thousand Rie, Yuko out of the thicket, Toru Matsuura, Koji Abe Neurological Therapeutics 29(5): 668-668, 2012. |
Effect on episode of care of the cerebral white matter lesion in 3D-04 Alzheimer type dementia Shigeru Kimura will, Masato Ishibashi, Kenichi Kabuuchi, Toshiro Okazaki, Takuya Hanaoka, Teruyuki Hirano, Toshihide Kumamoto Neurological Therapeutics 29(5): 668-668, 2012. |
Effect on digestive symptom examination of domperidone of patients with Alzheimer type dementia with the 3D-05 Rivastigmine administration Osamu Kano 1, Kiyoko Murata 1, 瓜田純久 2, 清塚鉄人 3, Ken Ikeda 1, Yasuo Iwasaki 1 Neurological Therapeutics 29(5): 669-669, 2012. |
3D-06 The clinical effect of Feruguard (ferulic acid) in dementia 小黒浩明, 石原正樹, 山口修平 Neurological Therapeutics 29(5): 669-669, 2012. |
It is examination by the event related potential the movement vision usability test in 3D-07 mild cognitive impairment patient and patients with Alzheimer disease Takao Yamazaki 1, 2, 大八木保政 3, Junichi Kira 3, Tobimatsu Shozo 1 Neurological Therapeutics 29(5): 669-669, 2012. |
Trial of the neurotization protective therapy with the G-CSF for patients with 3D-08 ALS Yusuke Moriya, Eiichiro Nagata, Toshiya Takizawa Neurological Therapeutics 29(5): 669-669, 2012. |
Effect of the edaravone administration in the amyotrophic lateral sclerosis /Parkinson dementia composition patients of the 3D-09 Kii peninsula 小久保康昌 1, Satoru Morimoto 2, 10, Nakagawa dream 3, Koichi Miyazaki 3, Shigeki Kuzuhara 4 Neurological Therapeutics 29(5): 670-670, 2012. |
Long-term follow-up of the antiandrogen therapy for the 3D-10 spinal and bulbar atrophy Kinya Ishikawa, 太田浄文, Makoto Takahashi, 水澤英洋 Neurological Therapeutics 29(5): 670-670, 2012. |
Examination of the effect of treatment for lower motor neuron syndrome(LMNS) of 3D-11 intravenous immune globulin therapy (IVIg) Kanako Yasui, Seiichi Ono Neurological Therapeutics 29(5): 670-670, 2012. |
Examination of the zonisamide therapy for the spinal cord motoneuron disorder of the 3D-12 Wobbler mouse 平山剛久, Ken Ikeda, Yasuhiro Yoshii, Seiichi Kawabe, Yasuo Iwasaki Neurological Therapeutics 29(5): 670-670, 2012. |
About the effect that clinical condition progression of 3D-13 amyotrophic lateral sclerosis speed gives to an effect of the rehabilitation Yutaka Kikuchi 1, Taku Tsukamoto 1, Saito 1, Hosei, Yasushi Asakura 1, Etsu Kodama will 1, Sakaki Chie 1, Wakui Mamiko 1, 内川茉美 1, Megumi Nakayama 1, Beautiful master 2 Neurological Therapeutics 29(5): 671-671, 2012. |
Present conditions - of the role - Tsugaru area of the backward hospital in the 3D-14 amyotrophic lateral sclerosis (ALS) practice Jinichi Nunomura Neurological Therapeutics 29(5): 671-671, 2012. |
Through 1 case of the effect spastic paraplegia of the physical therapy in the 3D-15 Baclofen intraspinal injection therapy Keiichiro Terayama 1, Ken Nagao tree 2, Takatsugu Sakakibara 3, Akihiro Ogawa 1, Takashi Akiba 1, Masahiko Kishi 3 Neurological Therapeutics 29(5): 671-671, 2012. |
Two cases that were regarded as Crowned dens syndrome which occurred for 3E-01 fever and latter neck pain Nobuko Sakai, Maho Suzuki, Yasuo Aota, Naoyuki Kitagawa, Michio Sakurai Neurological Therapeutics 29(5): 672-672, 2012. |
Two cases of the acute cervical vertebrae inflammatory disorder that recovered completely by 3E-02 early diagnosis, treatment Kunihiko Asakura, 木澤真努香, Akihiro Ueda, Tadayuki Miyashita, The Hitoshi Ishikawa truth, 武藤多津郎 Neurological Therapeutics 29(5): 672-672, 2012. |
One case of the idiopathic cranial hypertrophic pachymeningitis that 3E-03 Cyclophosphamide pulse therapy was successful, and cerebrospinal fluid findings were normalized 朴貴瑛 1, Masayuki Tahara 1, Hideyuki Sawada 1, Tetsuro Konishi 2 Neurological Therapeutics 29(5): 672-672, 2012. |
One case of the IgG4-related hypertrophic cranial pachymeningitis that presented an orbital apex syndrome during 3E-04 steroid weight loss Masaoki Iwanami, Tomohiro Ogawa, Tadashi Takiguchi daylight, Tomoyuki Miyamoto Neurological Therapeutics 29(5): 672-672, 2012. |
Rheumatoid factor, one patient of the hypertrophic brain pachyleptomeningitis that an antibody is peptide-positive anticitrulline who received 3E-05 Infliximab treatment Hogari ten thousand plum child, Shinichi Kashida, Izumi Kochi, Masatoyo Nishizawa Neurological Therapeutics 29(5): 673-673, 2012. |
The actual situation of the main cause and treatment in our country of the hypertrophic cranial pachymeningitis based on the 3E-06 whole country clinical epidemiology findings Satoshi Yonekawa 1, Takuya Matsushita 1, Takahisa Tateishi 1, 楠進 2, Junichi Kira 1 Neurological Therapeutics 29(5): 673-673, 2012. |
One case of the spinal sarcoidosis that occurred for 3E-07 acute myelopathy, and showed the improvement of significant neurologic symptoms by steroid therapy Land Yuichi, 渡辺宏久, Naoki Atsuta, 伊藤瑞規, Origin of Sofue Neurological Therapeutics 29(5): 673-673, 2012. |
39 years old man case of CNS sarcoidosis that resulted in 3E-08 subacute highly advanced dysfunction Fuyuki Tateno 1, Takatsugu Sakakibara 1, Yoshiyuki Sasaki 1, Yohei Tsuyusaki 1, Masahiko Kishi 1, Rikitake Hagino 2 Neurological Therapeutics 29(5): 673-673, 2012. |
One patient who responded to steroid-pulse therapy for a cerebellum symptom of the 3E-09 chronicity progressive form neuro-Behcet disease Takasuke Takagi, Akiko Onohara, High period sincerity, 三輪道然, Shindo Yorimasa, Yoshihisa Takiyama Neurological Therapeutics 29(5): 674-674, 2012. |
One case of Paget's bone disease that produced 3E-10-prone cranial nerve palsies Yamaguchi sum reason, Daisuke Noto, Yasuko Matsumoto Neurological Therapeutics 29(5): 674-674, 2012. |
It is a problem in the long-term treatment clinical analysis of the 3E-11 polymyalgia rheumatica Mutsuko Araki, Kenichi Ishikawa, Takeshi Kitamura, Toshi Kataoka Neurological Therapeutics 29(5): 674-674, 2012. |
Effect of tacrolimus on elderly women with suspected MPO-ANCA-related vasculitis that a lesion confined in 3E-12 central nerve Kazuhiro Endo, Juri Hasegawa Neurological Therapeutics 29(5): 674-674, 2012. |
2 cases of Parkinson disease that presented with dysesthesia to lower limbs for 3E-13 long term, and was refractory 白石眞, Maki childhood, Kinaoshi, Saza, Yasuhiro Hasegawa Neurological Therapeutics 29(5): 675-675, 2012. |
One case of patients with levodopa-responsive poor Parkinson disease that after giving 3E-14 Zonisamide, an exercise symptom improved in a short term Taku Nishida, Ogura etiquette, Kazunori Imai, Yasuhiro Ito, Takeshi Yasuda Neurological Therapeutics 29(5): 675-675, 2012. |
One case of the Parkinson's syndrome that 3E-15 antiParkinson disease medicine was invalid, and showed a lesion to both globus pallidus in MRI Takeshi Watanabe, Seiichi Ono Neurological Therapeutics 29(5): 675-675, 2012. |
82 years old woman case of Parkinson disease that dyspnea due to the 3E-16 stridor occurred in suddenly Toyota 1,000 Junko, Jun Umehara, 岡尚省 Neurological Therapeutics 29(5): 675-675, 2012. |
Parkinson disease that responded to combination of Rivastigmine patch and ergotherapy for 3E-17 higher nervous function, movement disorder Taku Kuwahara oneself 1, Keiko Kato 1, Shinsuke Hamada 1, Hiroyuki Soma 1, Sanae Honma 1, Asako Takei 1, Itaru Tamura 2, Keiko Hamada 1, Moriwaka Fumio 1, Kunio Tashiro 1 Neurological Therapeutics 29(5): 676-676, 2012. |
One case of the progressive supranuclear palsy who had the 3E-18 cerebellar syndrome Tomoaki Tsujii, Yutaka Iwaki still, Noriko Nishikawa, Masahiro Nagai, Masahiro Nomoto Neurological Therapeutics 29(5): 676-676, 2012. |
Long-term change of the clinical symptom after the liver transplantation in patients with 3E-19 transthyretin Y114C type hereditary brain amyloid angiopathy 奥村幸祐 1, Taro Yamashita 1, Machiko Tateishi 1, Oshima Toshinori 1, Akihiko Ueda 1, Yohei Misumi 1, Tomoo Hirahara 1, Seiji Honda 1, Mitsuharu Ueda 2, Great Hikaru Hayashi sense 2, Masaru Yamashita 1, Yasushi Maeda 1, Yuki Ando male 1 Neurological Therapeutics 29(5): 676-676, 2012. |
The spread between 3E-20α synuclein cells is inhibited by dynamin function inhibition 長谷川隆文, 今野昌俊, 三浦永美子, 菅野直人, 菊池昭夫, 青木正志, 武田篤 Neurological Therapeutics 29(5): 676-676, 2012. |
One case of the pineal primary glioblastoma that occurred for hydrocephalus without presenting the enlargement of the 3E-21 primary tumor Yosuke Miyachi 1, Daisuke Watanabe 1, Suzuki dream 2 Neurological Therapeutics 29(5): 677-677, 2012. |
43 years old man case of lymphoplasmacyte-rich meningioma treated effectively with 3E-22 steroid-pulse therapy Fuyuki Tateno 1, Takatsugu Sakakibara 1, Yoshiyuki Sasaki 1, Yohei Tsuyusaki 1, Masahiko Kishi 1, Hiroyuki Hiruta 2, Ken Nagao tree 3 Neurological Therapeutics 29(5): 677-677, 2012. |
Two cases of the serotonin syndrome that 3E-23 Cypropheptadine was effective Haruyuki Hiraga, One step of islet, Carp edge Katsura, Boss Ikuo Neurological Therapeutics 29(5): 677-677, 2012. |
One case of ganciclovir encephalopathy that disturbance of consciousness improved by 3E-24 haemodialysis Sakamoto light, Makito Hirano, Shuichi Ueno, Nakamura male product Neurological Therapeutics 29(5): 677-677, 2012. |
One case of limbic encephalitis type Hashimoto encephalopathy that assumed 3E-25 partial epilepsy and amnesia a cardinal symptom 岸谷融 1, Akiko Matsunaga 1, Ishitobi sincerity 2, Asano Mizuki 2, Masamichi Igawa 1, Osamu Yamamura 1, Tadanori Hamano 1, Hirohiko Kimura 3, Yuji Wada 2, Makoto Yoneta 1 Neurological Therapeutics 29(5): 678-678, 2012. |
One case of refractory status epilepticus where 3E-26 Phenobarbital bolus dose was effective Takeshi Uenaka, Kaneji Sekiguchi, Old Tomohiro Waku, Norio Karita, Tatsushi Toda Neurological Therapeutics 29(5): 678-678, 2012. |
Two cases of NMDA type glutamate receptor complex antibody with the outcome that 3E-27 has good-negative ovarian teratoma-related encephalitis Bell mountain Kohei 1, 藥師寺祐介 1, Snow bamboo Motohiro 1, 中橋弘顕 2, Masanori Masuda 3, Yukitoshi Takahashi 4, Keiko Tanaka 5, Hideo Hara 1 Neurological Therapeutics 29(5): 678-678, 2012. |
One case that there were no teratomas 3E-28 refractory antiGluR antibody positive encephalitis, but obtained significant improvement by bilateral oophorectomy Akihiro Ueda 1, Hitoshi Ishikawa truth 1, Naoki Kawamura 1, Island Sayuri 1, 木澤真努香 1, Kunihiko Asakura 1, Yukitoshi Takahashi 2, 武藤多津郎 1 Neurological Therapeutics 29(5): 678-678, 2012. |
One case of the non-paraneoplasic anti-NMDA receptor encephalitis that responded to ciclophosphamide high dose therapy one year after the 3E-29 onset Daisuke Ijima, Jun Kaneko Taro, 飯塚高浩, Junichi Hamada Neurological Therapeutics 29(5): 679-679, 2012. |
One case of antimGluR1 antibody-positive subacute cerebellum incontinence where 3E-30 simplicity plasma exchange and IVIg therapy was effective Hitoshi Harada child, Yuichi Hayashi, 吉倉延亮, Teruhiro Komura, Akira Kimura husband, Takashi Inuzuka Neurological Therapeutics 29(5): 679-679, 2012. |
Importance of the effect on cardiovascular system with the oral 3E-31 multiple sclerosis therapeutic drug fingolimod induction and the monitoring Xinye Masaaki 1, Toshiyuki Fukazawa 2, South Naoya 3, Jun Tashiro 3, Naoto Fujiki 3, Shizuka Doi tree 3, Seishi Kikuchi 3 Neurological Therapeutics 29(5): 679-679, 2012. |
Examination for the side effect - one's own experiments case at the 3E-32 Fingolimod induction Shoichi Miyamoto, Kazuo Takada, Yoshinobu Mitsui, 楠進 Neurological Therapeutics 29(5): 679-679, 2012. |
Clinical significance of the interferonβ neutralizing antibody in 3E-33 multiple sclerosis treatment 中島一郎1, 佐藤ダグラス1, 深澤俊行2, 清水優子3, 富沢雄二4, 横山和正4, 三須建郎5, 藤原一男5, 青木正志1 Neurological Therapeutics 29(5): 680-680, 2012. |
interferon self-administration instruction to the 3E-34 MS patients Noriko Sugimoto, Akiko Yamamoto, Sakamoto light, Shuichi Ueno, Makito Hirano, Nakamura male product Neurological Therapeutics 29(5): 680-680, 2012. |
Examination of acute care for 3E-35 neuromyelitis optica (NMO)/NMO spectrum disorders and the prevention of recurrence Satoshi Kawabata 1, 浦茂久 1, Laboratory of Kuroshima beauty 1, Kazuto Yoshida 1, Toshiyuki Takahashi 2 Neurological Therapeutics 29(5): 680-680, 2012. |
Examination of the utility of the Cyclosporin single administration in recurrent suppression of 3E-36 Neuromyelitis Optica spectrum disorder Shohei Ikeda, Wataru Takita, Tetsuro Ishihara, Naoki Hattori Neurological Therapeutics 29(5): 680-680, 2012. |
1 autopsy case of the neuromyelitis optica that was under the medical treatment for a long term more than 3E-37 40 years Fujii Chihiro, Yu Sato, Toshiki Mizuno, Nakagawa teachings of Buddha Neurological Therapeutics 29(5): 681-681, 2012. |